GB2188915A - Tablets - Google Patents
Tablets Download PDFInfo
- Publication number
- GB2188915A GB2188915A GB08608602A GB8608602A GB2188915A GB 2188915 A GB2188915 A GB 2188915A GB 08608602 A GB08608602 A GB 08608602A GB 8608602 A GB8608602 A GB 8608602A GB 2188915 A GB2188915 A GB 2188915A
- Authority
- GB
- United Kingdom
- Prior art keywords
- salt
- tablets
- particles
- caking agent
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 claims abstract description 19
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000001427 coherent effect Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 5
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 abstract description 32
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 9
- 239000011780 sodium chloride Substances 0.000 abstract description 7
- 238000001035 drying Methods 0.000 abstract description 4
- 239000008188 pellet Substances 0.000 abstract description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000002178 crystalline material Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- UETZVSHORCDDTH-UHFFFAOYSA-N iron(2+);hexacyanide Chemical compound [Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] UETZVSHORCDDTH-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
- C01D3/00—Halides of sodium, potassium or alkali metals in general
- C01D3/22—Preparation in the form of granules, pieces, or other shaped products
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
- C01D3/00—Halides of sodium, potassium or alkali metals in general
- C01D3/26—Preventing the absorption of moisture or caking of the crystals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Tablets, pellets, blocks formed of particles of common salt or other crystallisable material can be produced without a tendency to disintegrate, even when an anti-caking agent is included in the material being tabletted, by moistening the tablet and then drying it, or by moistening the particles either just before or during the tabletting and then drying.
Description
SPECIFICATION
Tablets
This invention relates to tablets, pellets, blocks and the like (hereinafter referred to as "tablets") of salt or other crystalline material which may be of organic or inorganic nature. More particularly, though not exclusively, the present invention relates to tablets consisting of or comprising common salt (sodium chloride).
Common salt tablets are currently used for medicinal and culinary purposes. They are also used in water softening and, in the form of blocks, are used for animal licks. The function of such tablets is to enable controlled release or dissolving of the salt without premature disintegration of the tablet. For example, in the water softening field, it is undesirable for the salt tablet to disintegrate because the fine salt particles resulting from disintegration of the tablet can cause undue wear and sticking of automatic valves in the water softening system and does not lead to effective utilization of the salt.
It is common practice to include an anti-caking agent in salt in orderto maintain it in afree-running condition. In this way, handling, storage and transportof salt isfacilitated. Withoutthe provision of an anti-caking agent, the saltforms into solid lumps, which is highly undesirable, However, it has heretofore been impossible to form tablets having the required coherence (i.e. lackofatendencyto disintegrate) using salt containing an anti-caking agent. Thus, it has been the practice to form tablets from salt which does not contain an anti-caking agent, with all the attendant difficulties in handling, transport and storage.
Most surprisingly, we have now found thattablets having the required coherence can be produced from salt containing anti-caking agent if, afterthe tablet has been formed, it is moistened and then dried.
Thus, according to one aspect of the present invention, there is provided a method of manufacturing tablets (as herein defined) of particles of salt or other crystallisable material, comprising the steps of compacting such particles to form tablets, moistening the tablets, and then removing the moisture therefrom.
In an alternative embodiment, the salt is moistened slightly either just before or during the tabletting operation and is then dried. The moistened salt may be in the form of commercially available undried salt typically having a water content of about 2.5% Although the mechanism is not yet fully understood, it is believed that moistening ofthe tablet serves to dissolve a small proportion of the material at the surface of the particles and that, after removal of the moisture, bridges of salt or other crystalline material are established which extend between the particles in order to hold such particles in a coherent state, thus overcoming the effect of the anti-caking agent.
Thus, according to another aspect of the present invention,there is provided a tablet (as herein defined) of particles of salt or other crystallisable material, wherein the particles are held together in a coherent state within the tablet by bridges of said material which extend between the particles.
Whilstthe present invention is particularly concerned with tablets formed of salt or other crystallisable material which also contain an anti-caking agent, it will be appreqiated that the concept of the present invention can also be applied to tablets formed ofsaltorothercrystallisable material which do not contain an anti-caking agent if it is desired to improve furtherthe coherence of a tablet containing no anti-caking agent.
Typical anti-caking agents for common salt are aluminosilicatesofsodium or potassium, magnesium carbonate and sodium or potassium salts of carboxylic acid such as citric acid, oleic acid, stearic acid and palmitic acid, and the present invention is applicable to tablets containing such caking agents. In particular, however, the present invention is applicable to tablets formed of salt containing the hexacyanoferrate II salt of sodium or potassium, which is the most common anti-caking agent for common salt. The anti-caking agent is usally provided in the salt at a concentration in the range of 5 to 15 ppm by weight to provide the necesssaryanti-caking properties.
During the moistening step, the tablets can be moistened with water, either in the form of fine spray or droplets, or by briefly immersing thetablets in water. Alternatively,thetablets may be moistened with a solution of salt or other crystallisable material, e.g brine. Any concentration of solution up to a saturated solution may be used. The amount of liquid required is not critical, butwe have found that quite a light moistening of the surface ofthetablet appears to be sufficient. If it is desired to introduce other materials, such as trace elements, into the tablet, then these can be introduced conveniently by incorporating them into the solution used to moisten the tablets. For example, trace elements may be advantageously incorporated into the tablets when such areintheform of animal licks.
After moistening, the tablets are dried essentially to remove the added moisture. Drying can be effected by raising the temperature in an oven to a temperature typically between 1 000C and 200"C for a period of time to effect drying. Alternatively, the moistened tablets can be dried in a microwave oven.
In a particular example of the present invention, tablets are formed in a tabletting machine, (e.g a
COLTON 31 STATION DOUBLE ROTATORY TABLET
PRESS) using salt having a particle size distribution such that 2.5% of the particles are retained on an 850 micron sieve, 70% are retained on a 300 micron sieve and 99.9% are retained on a 75 micron sieve. The salt contains 5to 5 ppm by weight of sodium hexacyanoferrate II as an anti-caking agent and is better than 99.9% by weight pure sodium chloride.
Thetabletting machine produces tablets having a diameter of 5to 30 millimetres (in this example 25 mm) and athickness of 5to 20 mm (in this example 12 mm) but the tablet dimensions are not critical to the invention. After moistening the tablets with a fine water spray, the tablets are then dried in an oven at 1 70 C for 2 minutes. The resultanttablets are found to be coherent in use in that they do not disintegrate when immersed in water and this is believed to be due to bridges of salt which are formed between the salt particles within the tablet.
Claims (8)
1. A method of manufacturing tablets (as herein defined) of particles of salt or other crystallisable material, comprising the steps of compacting such particles to form tablets, moistening the tablets, and then removing the moisture therefrom.
2. A modification of the method as claimed in claim 1, wherein the salt is moistened slightly either just before or during the tabletting opeation and is then dried.
3. A method as claimed in claim 2, wherein the moistened salt is in the form of undried salttypically having a water content of about 2.5%.
4. A method as claimed in any preceding claim, wherein said tablets also contain an anti-caking agent.
5. Atablet (as herein defined) of particles of salt or other crystallisable material, wherein the particles are held together in a coherent state within the tablet by bridges of said material which extend between the particles.
6. Atablet as claimed in claim 5, which also contains an anti-caking agent.
7. A method as claimed in claim 1, substantially as hereinbefore described.
8. Atabletwhen produced bya method as claimed in anyone of claims 1 to 4 or claim 7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8608602A GB2188915B (en) | 1986-04-09 | 1986-04-09 | Tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8608602A GB2188915B (en) | 1986-04-09 | 1986-04-09 | Tablets |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8608602D0 GB8608602D0 (en) | 1986-05-14 |
| GB2188915A true GB2188915A (en) | 1987-10-14 |
| GB2188915B GB2188915B (en) | 1989-11-22 |
Family
ID=10595902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8608602A Expired GB2188915B (en) | 1986-04-09 | 1986-04-09 | Tablets |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2188915B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0998921A1 (en) * | 1998-09-22 | 2000-05-10 | Sato Pharmaceutical Co., Ltd. | Method and apparatus for manufacturing tablet capable of quick disintegration in oral cavity |
| FR2786760A1 (en) * | 1998-12-07 | 2000-06-09 | Solvay | CYLINDRICAL PELLET OF AGGLOMERATED SALT |
| WO2000073208A1 (en) * | 1999-05-27 | 2000-12-07 | Akzo Nobel N.V. | Pressed products of non-caking salt |
| US6491964B1 (en) | 1999-05-27 | 2002-12-10 | Akzo Nobel N.V. | Pressed products of non-caking salt and process of making |
| EP1769682A4 (en) * | 2004-07-02 | 2010-08-25 | Meiji Dairies Corp | Solid milk and method of producing the same |
| CN101437404B (en) * | 2005-12-28 | 2012-07-04 | 株式会社明治 | Solid milk and its preparation method |
| WO2013001052A1 (en) | 2011-06-30 | 2013-01-03 | Eurotab | Method for manufacturing soluble coffee tablets |
| DE102020124503A1 (en) | 2020-09-21 | 2022-03-24 | Showerplus Entwicklungs- Und Vertriebsgesellschaft Mbh | Pressed shaped body and applicator for receiving such a shaped body |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB911130A (en) * | 1959-11-10 | 1962-11-21 | Dominion Tar & Chemical Co | Salt production |
| GB1384384A (en) * | 1971-08-27 | 1975-02-19 | Ici Ltd | Agglomeration of soluble particles |
| GB2104882A (en) * | 1981-08-28 | 1983-03-16 | Coal Ind | Briquette for smelting process and method of its production |
-
1986
- 1986-04-09 GB GB8608602A patent/GB2188915B/en not_active Expired
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB911130A (en) * | 1959-11-10 | 1962-11-21 | Dominion Tar & Chemical Co | Salt production |
| GB1384384A (en) * | 1971-08-27 | 1975-02-19 | Ici Ltd | Agglomeration of soluble particles |
| GB2104882A (en) * | 1981-08-28 | 1983-03-16 | Coal Ind | Briquette for smelting process and method of its production |
Non-Patent Citations (1)
| Title |
|---|
| THE THEORY AND PRACTICE OF INDUSTRIAL PHARMACY LACKMAN LIEBERMAN & KANIG 2ND EDITION PAGES 321-358 * |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0998921A1 (en) * | 1998-09-22 | 2000-05-10 | Sato Pharmaceutical Co., Ltd. | Method and apparatus for manufacturing tablet capable of quick disintegration in oral cavity |
| US6316026B1 (en) | 1998-09-22 | 2001-11-13 | Sato Pharmaceutical Co., Ltd. | Method and apparatus for manufacturing tablet capable of quick disintegration in oral cavity |
| FR2786760A1 (en) * | 1998-12-07 | 2000-06-09 | Solvay | CYLINDRICAL PELLET OF AGGLOMERATED SALT |
| EP1008554A1 (en) * | 1998-12-07 | 2000-06-14 | SOLVAY & Cie (Société Anonyme) | Cylindrical pastille of agglomerated salt |
| WO2000073208A1 (en) * | 1999-05-27 | 2000-12-07 | Akzo Nobel N.V. | Pressed products of non-caking salt |
| US6491964B1 (en) | 1999-05-27 | 2002-12-10 | Akzo Nobel N.V. | Pressed products of non-caking salt and process of making |
| RU2247072C2 (en) * | 1999-05-27 | 2005-02-27 | Акцо Нобель Н.В. | Compacted products from non-caking salt |
| AU2005260485B2 (en) * | 2004-07-02 | 2010-12-02 | Meiji Dairies Corporation | Solid milk and method of producing the same |
| EP1769682A4 (en) * | 2004-07-02 | 2010-08-25 | Meiji Dairies Corp | Solid milk and method of producing the same |
| CN1980576B (en) * | 2004-07-02 | 2012-07-18 | 株式会社明治 | Solid milk and its preparation method |
| US8828471B2 (en) | 2004-07-02 | 2014-09-09 | Meiji Co., Ltd. | Method for manufacturing solid milk |
| CN101437404B (en) * | 2005-12-28 | 2012-07-04 | 株式会社明治 | Solid milk and its preparation method |
| US9635869B2 (en) | 2005-12-28 | 2017-05-02 | Meiji Co., Ltd. | Solid milk and method of making the same |
| WO2013001052A1 (en) | 2011-06-30 | 2013-01-03 | Eurotab | Method for manufacturing soluble coffee tablets |
| EP2725920B1 (en) * | 2011-06-30 | 2016-03-16 | Eurotab | Method for manufacturing soluble coffee tablets |
| DE102020124503A1 (en) | 2020-09-21 | 2022-03-24 | Showerplus Entwicklungs- Und Vertriebsgesellschaft Mbh | Pressed shaped body and applicator for receiving such a shaped body |
| EP3984518A1 (en) | 2020-09-21 | 2022-04-20 | Showerplus Entwicklungs- und Vertriebsgesellschaft mbH | Pressed moulding and applicator for holding such a moulding |
Also Published As
| Publication number | Publication date |
|---|---|
| GB8608602D0 (en) | 1986-05-14 |
| GB2188915B (en) | 1989-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3653914A (en) | Production of tablets | |
| DE3171538D1 (en) | Process for the preparation of a storage-stable, easily soluble granulated compound containing a bleach activator | |
| EP0196075A2 (en) | Cleaning system for contact lenses and process for cleaning the same | |
| GB2188915A (en) | Tablets | |
| US3121663A (en) | Carbon dioxide releasing laxative suppository | |
| EP0940088A3 (en) | Ruminant feed additive composition and process for producing the same | |
| DE2227502C3 (en) | Process for the production of calcium hypochlorite granules | |
| EP0272312B1 (en) | Effervescent granular material, process for its production, and use of said material | |
| DE04076118T1 (en) | Stable solid composition of enalapril salt and its preparation | |
| ATE60711T1 (en) | PHARMACEUTICALS CONTAINING CLODRONATE AND METHOD OF MANUFACTURE THE SAME. | |
| US4013442A (en) | Process for encapsulating particles by in-situ formation of a metal carbonate coating | |
| US4250140A (en) | Method and composition for retarding water evaporation | |
| US3802914A (en) | Method of treating lactose | |
| US3663271A (en) | Surface-modified acid crystals and process for their preparation | |
| US2767146A (en) | Method of making cleaning | |
| Lowry et al. | The properties of powders. Part I.—The caking of salts | |
| US4162990A (en) | Method and composition for retarding water evaporation | |
| HUP0003566A2 (en) | Process for producing dosage form and prodact of the method and use thereof | |
| JP5414146B2 (en) | Solid pharmaceutical preparation containing levothyroxine and / or liothyronine salt | |
| JP2535975B2 (en) | Molding composition for water treatment | |
| US2188944A (en) | Tableted polychlorophenol salts | |
| GB838667A (en) | Process for forming sodium perborate crumbs | |
| US4394336A (en) | Production of tablets of sodium dichloroisocyanurate | |
| US3433590A (en) | Dry stabilized alkali metal dithionite compositions | |
| US3522092A (en) | Treatment of sugar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20010409 |